Cymabay Therapeutics Inc. (CBAY)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
VenBio Select Advisor

Kurt Von Emster

10,300,000 $36,050 0.66%
2.
Commodore Capital

Egen Atkinson And Michael Kramarz

5,738,500 $20,085 3.22%
3.
Nantahala Capital Management

Wilmot B. Harkey And Daniel Mack

2,474,659 $8,661 -7% 0.56%
4.
Baker Bros. Advisors

Julian Baker And Felix Baker

2,170,464 $7,597 0.04%
5. 1,703,235 $5,961 -5% 1.6%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$1.95 51,301 Officer, Director 171,301 2022-06-06 Filing
$3.04 20,000 Officer 20,000 2022-01-19 Filing
$4.30 5,000 Officer, Director 120,000 2019-10-10 Filing
$5.55 3,100 Officer, Director 115,000 2019-09-23 Filing
$5.50 1,900 Officer, Director 111,900 2019-09-20 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$9.02 11,675 Director 0 2019-02-07 Filing
$7.43 53,492 Director 131,036 2018-12-18 Filing
$8.17 88,889 Director 184,528 2018-12-17 Filing
$13.00 5,000 Officer 0 2018-08-29 Filing
$12.51 920 Director 18,316 2018-06-05 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 5,905,400 $20,669 6.19%
2. 3,665,062 $12,828 0%
3. 2,325,833 $8,140 7.34%
4. 1,944,650 $6,806 0%
5. 1,787,094 $6,255 2.01%
News See All